Answers are grounded in this paper and cite their sources.
Background Whether age-associated methylation changes can be remodelled while preserving individual identity remains a key challenge. Methods We applied a conditional diffusion model for methylome age-associated signature remodelling. A VAE compressed 15,000 CpGs into 64 latent dimensions, followed by diffusion training under cell-type constraints. Ten-fold cross-validation compared six methods using identity correlation, Clock MAE, and cell-type correlation. Results Our method significantly outperformed linear interpolation, nearest neighbor, and PCA regression in identity preservation and Clock MAE ( p < 0.001, d = 4.04–5.68), matching cVAE and DDPM. Fifteen driver dimensions were identified. Driver CpGs significantly enriched at POLR2A binding sites (fold = 3.13, p = 0.0044). Metformin-induced changes correlated with remodelling direction ( r = 0.518, p = 0.048). Six CMap-predicted drugs overlapped with DrugAge, including canagliflozin (9.0% lifespan extension in mice). Saliva validation supported cross-tissue generalizability ( r =-0.406, p = 1.47 × 10⁻⁶). Conclusions Age-associated methylation signature remodelling proceeds via targeted reprogramming along 15 driver dimensions, preferentially modulating POLR2A-bound regions while preserving individual identity, providing a framework for epigenomic studies of aging. Clinical trial number Not applicable.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: